INFLUENCEOF PRETRANSPLANT CLASS I AND II NON-DONOR-SPECIFIC ANTI-HLA IMMUNIZATION ONIMMUNOLOGIC OUTCOME AND GRAFT SURVIVAL IN KIDNEY TRANSPLANT RECIPIENTS

被引：0
|
作者：
Staeck, Anja [1 ]
Khadzhynov, Dmytro [1 ]
Lachmann, Nils [2 ]
Kleinsteuber, Anna [1 ]
Lehner, Lukas [1 ]
Duerr, Michael [1 ]
Budde, Klemens [1 ]
Halleck, Fabian [1 ]
Staeck, Oliver [1 ]
机构：
[1] Charite, Nephrol, D-13353 Berlin, Germany
[2] Charite, Transfus Med, D-13353 Berlin, Germany
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP658
引用
收藏
页码：315 / 315
页数：1
相关论文
共 50 条
  • [21] THE ROLE OF IGA ANTI-HLA CLASS-I ANTIBODIES IN KIDNEY-TRANSPLANT SURVIVAL
    KOKA, P
    CHIA, D
    TERASAKI, PI
    CHAN, H
    CHIA, J
    OZAWA, M
    LIM, E
    TRANSPLANTATION, 1993, 56 (01) : 207 - 211
  • [22] Donor-Specific Anti-HLA Antibodies at the Time of Kidney Transplant Biopsy Associates With Late Graft Failure in Pediatric Renal Transplant Recipients.
    Fichtner, A.
    Hoecker, B.
    Rieger, S.
    Waldherr, R.
    Opelz, G.
    Suesal, C.
    Toenshoff, B.
    TRANSPLANTATION, 2014, 98 : 504 - 504
  • [23] Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation
    Li, Xiaobei
    Ishida, Hideki
    Yamaguchi, Yutaka
    Tanabe, Kazunari
    TRANSPLANT INTERNATIONAL, 2008, 21 (12) : 1145 - 1152
  • [24] IDENTIFICATION OF ANTI-HLA CLASS II ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS BASED ON EXPERIENCE OF OUR CENTER
    Dukic, Tatjana Marijan
    Dmitrovic, Jelena M.
    Andric, Zorana P.
    Soskic, Bjanka B. Lako
    Simonovic, Ruzica
    HLA, 2016, 87 (04) : 247 - 247
  • [25] Impact of Preformed, Donor-Specific, Anti-HLA Antibodies on Combined Liver Kidney Transplant Outcome
    Mandal, Saptarshi
    Du, Zeying
    Weidner, Jerome
    Ramahi, Sana
    Kunnavakkam, Rangesh
    Te, Helen
    Marino, Susana R.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (03) : 506 - 506
  • [26] Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients
    Morrison, Alexander H.
    Gupta, Meera
    Lloyd, Kelsey
    Trofe-Clark, Jennifer
    Lim, Mary Ann
    Limonte, Christine
    Levine, Matthew H.
    Sawinski, Deirdre
    Kamoun, Malek
    Porrett, Paige M.
    TRANSPLANTATION DIRECT, 2019, 5 (08):
  • [27] Deleterious effect of preformed anti-HLA class I donor-specific antibodies despite intravenous immunoglobulin induction treatment in living kidney transplant recipients
    Akalin, E
    Ames, S
    Sehgal, V
    Murphy, B
    Fotino, M
    Friedlander, R
    Bromberg, JS
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 324 - 324
  • [28] The utility of comprehensive assessment of donor specific anti-HLA antibodies in the clinical management of pediatric kidney transplant recipients
    Gloor, James M.
    PEDIATRIC TRANSPLANTATION, 2011, 15 (06) : 557 - 563
  • [29] Belatacept in Kidney Transplant Recipients with Preformed Donor Specific Anti-HLA Antibodies: Results of the BELACOR Trial.
    Leibler, C.
    Canoui, F.
    Matignon, M.
    Rondeau, E.
    Zarour, A.
    Durrbach, A.
    Malard, S.
    Grimbert, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 293 - 293
  • [30] Acute Antibody Mediated Rejection Treatment Impact on Class I and Class II Anti-HLA Antibodies in Pediatric Kidney Transplant Recipients.
    Kincaide, E.
    Hitchman, K.
    Hall, R.
    Yamaguchi, I.
    Crowther, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 705 - 706
12345